Rabourn Amy Zaremba - 16 Mar 2026 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role: Head of Fin. Quality Assurance
Signature: /s/ Amy Rabourn
Issuer symbol: IRD
Transactions as of: 16 Mar 2026
Net transactions value: -$14,770
Form type: 4
Filing time: 18 Mar 2026, 16:11:39 UTC
Previous filing: 26 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Zaremba Rabourn Amy	Head of Fin. Quality Assurance	C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM	/s/ Amy Rabourn	18 Mar 2026	0001832343

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRD	Common Stock	Sale	$14,770	-2,816	-1.5%	$5.24	190,312	16 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.